National Gallbladder and Bile Duct Cancer Awareness Month raises awareness of these less common cancers. According to the American Cancer Society, about 12,300 people are diagnosed with gallbladder ...
Key Takeaways: Liquid biopsies can identify cancer-related biomarkers in body fluids like blood, saliva, or urine. This allows for cancer detection at earlier stages than traditional screening methods ...
Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had higher-than-normal expression of the FGFR2 protein, and FGFR2 inactivation delayed ...
In a prospective cohort study of more than 85,000 adults in the United Kingdom, researchers at the National Institutes of Health (NIH) and University of Oxford found that individuals who engaged in ...
A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment’s effectiveness in patients with metastatic gastrointestinal ...
As part of a cutting-edge study aimed at restoring fertility in young male cancer survivors, a 26-year-old man who had childhood cancer has received the first known transplant of sperm-producing stem ...
In an internal HHS email announcing the office’s closure, shared by Inside Medicine and on social media, Simon wrote: “Over the last 3+ years, we have built meaningful connections and fruitful ...
City and state health agencies need the collaboration of CDC experts to help investigate disease outbreaks and other threats to public health.
Active surveillance spares men with low-risk prostate cancer, like me, from aggressive treatment and its side effects.
Hallmark star Brennan Elliott shared that his wife, Camilla Row, died this week after a yearslong battle with gastric cancer, also known as stomach cancer. “There is no easy way to say this but I know ...
“This feels like a genocide in the making,” said an HIV expert. The cuts also affect cancer and COVID-19 research and target women and LGBTQ, Latino and Black Americans.
A combo of Xtandi (enzalutamide) and Talzenna (talazoparib) does improve overall survival for men with advanced prostate cancer, compared with Xtandi alone.